Victory Capital Management Inc. Has $48.77 Million Holdings in Encompass Health Co. (NYSE:EHC)

Victory Capital Management Inc. decreased its position in Encompass Health Co. (NYSE:EHC - Free Report) by 7.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 528,061 shares of the company's stock after selling 43,958 shares during the quarter. Victory Capital Management Inc. owned about 0.52% of Encompass Health worth $48,766,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in EHC. Point72 Asset Management L.P. raised its holdings in Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock valued at $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Jennison Associates LLC bought a new stake in Encompass Health during the 4th quarter worth $52,094,000. abrdn plc bought a new position in Encompass Health in the fourth quarter valued at about $17,846,000. Thrivent Financial for Lutherans boosted its stake in shares of Encompass Health by 26.0% during the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock valued at $73,494,000 after purchasing an additional 156,938 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Encompass Health by 22.0% during the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock valued at $67,412,000 after purchasing an additional 126,000 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of research reports. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Barclays lifted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Ten research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $107.67.

Remove Ads

Encompass Health Trading Down 2.9 %

NYSE EHC traded down $2.81 during trading hours on Wednesday, hitting $94.18. 548,336 shares of the company's stock were exchanged, compared to its average volume of 635,410. Encompass Health Co. has a 1-year low of $74.27 and a 1-year high of $104.55. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The stock has a 50-day simple moving average of $97.18 and a 200 day simple moving average of $96.90. The firm has a market cap of $9.49 billion, a price-to-earnings ratio of 21.14, a PEG ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.10% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.